NIH-funded research R21 grant

Investigating a gene linked to Tourette syndrome

Official title: Exploring the role of the protocadherin CELSR3 in Tourette syndrome

Funded at University of Utah · NIH-10532254 · Data updated 2026-11-12

This study is looking at how a specific gene called CELSR3 might be linked to Tourette syndrome, using special mice to see how changes in this gene could help us understand the condition better and find new treatments for people with TS.

More Tourette Syndrome research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Utah
NIH-funded
Lab location1 site (Salt Lake City, United States)
Project startDecember 1, 2021
Project endSeptember 30, 2025
Funding year2023
Award (this year)$190,625
NIH project number5R21NS125519-02
Project IDNIH-10532254 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Tourette syndrome, particularly those with a family history of the disorder.

Less likely to help

Patients without a diagnosis of Tourette syndrome or those with other unrelated neurological disorders may not benefit from this research.

What this research studies

This research focuses on understanding the genetic factors contributing to Tourette syndrome (TS), particularly the role of the CELSR3 gene. By using transgenic mouse models with mutations in this gene, researchers aim to uncover how CELSR3 deficiency may lead to the development of TS. The study builds on recent findings that suggest protocadherins, proteins involved in cell communication, are significant in TS pathogenesis. This work could provide insights into more effective treatments for individuals affected by TS.

Why it matters

Potential benefit: If successful, this research could lead to targeted therapies that specifically address the underlying genetic causes of Tourette syndrome, improving treatment outcomes for patients.

How similar studies have gone: Previous research has shown promising results in understanding genetic contributions to Tourette syndrome, making this approach a continuation of successful investigations in the field.

Where this research is happening

  • University of Utah
    Salt Lake City, United States
    Active

Researchers

  • Principal investigator: Bortolato, Marco — University of Utah
  • Study coordinator: Bortolato, Marco

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.